Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has provided an update.
MindBio Therapeutics Corp. announced a non-brokered private placement to raise up to $1,100,000, offering AI Units and LIFE Units to investors. The proceeds will be used to advance their prediction technologies for intoxication detection and for general working capital. The company has also completed the development of clinical software for data collection and analysis, which will aid in deploying their intoxication detection technology in enterprise environments. The offering is subject to shareholder and regulatory approvals, and if completed, it will significantly increase the company’s share capital.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biotechnology company based in Vancouver, British Columbia. It focuses on developing novel treatments for mental health disorders and health prediction technologies using AI and machine learning. The company is involved in conducting clinical trials and health research, particularly in the area of drug and alcohol intoxication detection using speech.
Average Trading Volume: 1,055
Technical Sentiment Signal: Sell
Current Market Cap: C$1.02M
For an in-depth examination of MBIO stock, go to TipRanks’ Overview page.